Ra Chem Pharma

Hyderabad, India Founded: 1996 • Age: 30 yrs Minicorn Acquired By Advent International
API and formulations are developed and manufactured under contract.

About Ra Chem Pharma

Ra Chem Pharma is a Healthcare company based in Hyderabad (India) founded in 1996 by Ravi K Yerra and J Rajender Rao, and was acquired by Advent International in July 2020. API and formulations are developed and manufactured under contract. The company has 1,138 employees. Ra Chem Pharma was last valued at $17.09 million in June 2013. Its Indian entity Ra Chem Pharma Limited reported revenue of β‚Ή621 Cr. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals; 1 of its 3 listed competitors has raised funding.

Company details

RA Chem Pharma is a contract developer manufacturer of API formulations. They provide bioanalytical services such as HPLC GC, synthesize impurities working standards. Their API products are duloxetine, venlafaxine, orlistat, itraconazole, etc. The company is specialized in formulations development of oral control release site-specific release deliveries for anti-spasmodic, non-steroidal anti-inflammatory, anti-anxieties alpha1 receptor blockers. The company also claims to have completed more than three hundred BABE studies for various regulatory agencies.

  • Headquarters Hyderabad, India
  • Employees 1,138
  • Founders Ravi K Yerra, J Rajender Rao
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website rachempharma.com
  • Social LinkedIn
  • Acquired by Advent International (Jul 2020)
  • Legal Name Ra Chem Pharma Limited
  • Date of Incorporation 08 Jan, 1996
  • Jurisdiction Hyderabad, Andhra Pradesh, India
Key Metrics
  • Annual Revenue
    ₹621 Cr

    FY 2021 · +15% YoY

  • Net Profit
    ₹77.80 Cr

    FY 2021 · 13% margin

  • EBITDA
    ₹132 Cr

    FY 2021 · 21% margin

  • Latest Funding Round
    $339.58K (USD), Unspecified

    Jun 2013

  • Investors
  • Employee Count
    1,138
  • Acquired by
    Advent International

    & 1 more

    (Jul 2020)

Funding Insights of Ra Chem Pharma

  • Total Rounds 4
  • Last Round Unspecified β€” $339,584
  • First Round $920,415

    (Aug 2006)

  • Investors Count 4

All 4 funding rounds of Ra Chem Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2013$339,584Unspecified$17.09MOntario, Orchem International Trading
–
Oct 2011$805,972Unspecified$12.53MOntario, Orchem International Trading
–
Sep 2008$1.71MUnspecified$β€’β€’β€’β€’β€’Ontario, Orchem International Trading
Aug 2006$920,415Unspecified$β€’β€’β€’β€’β€’Ontario, Laxmi RA
Valuation history
DateValuationStage
Jun 2013$17.09Mβ€’β€’β€’β€’β€’β€’β€’β€’
Oct 2011$12.53Mβ€’β€’β€’β€’β€’β€’β€’β€’
Sep 2008$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Aug 2006$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of Ra Chem Pharma

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $17.09M (Jun 2013). 6 investors in total: 6 institutional.

Investors in Ra Chem Pharma

Ra Chem Pharma has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Joflo Industries, Ontario and Orchem International Trading.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity firm focused on multiple sectors
adventinternational.comSao Paulo, Brazil
Pharmaceutical products, medical instruments, and orthopaedic articles are wholesaled internationally.
Amsterdam, Netherlands
Manufacturing of centrifuges for chemical and pharmaceutical sectors in India.
jofloindustries.comHyderabad, India
Generics and API manufacturer
microlabsltd.comBengaluru, India
Premium access

Investor details for Ra Chem Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Ra Chem Pharma Limited (Ra Chem Pharma)

Ra Chem Pharma Limited is the primary company behind Ra Chem Pharma. The board of Ra Chem Pharma Limited currently have 7 directors; the longest-serving is Shweta Jalan, appointed in 2020. 24 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Shweta Jalan
DIN 00291675
Director27 Oct 20206 yrsRa Chem Pharma Limited
Abhijit Mangalmoy Mukherjee
DIN 08610857
Director27 Oct 20206 yrsRa Chem Pharma Limited
Pankaj Patwari
DIN 08206620
Director27 Oct 20206 yrsRa Chem Pharma Limited
Bhaskar Vemban Iyer
DIN 00480341
Director27 Oct 20206 yrsRa Chem Pharma Limited
Venkatanaga Kali Vetukuri Vara Prasada Raju
DIN 07267366
Managing Director10 Mar 20215 yrs 8 moRa Chem Pharma Limited
Jayant Bhalchandra Manmadkar
DIN 03044559
CFO16 Jul 20215 yrs 4 moRa Chem Pharma Limited
Anil Kumar Chanana
DIN 00466197
Additional Director15 Dec 20214 yrs 11 moRa Chem Pharma Limited

People of Ra Chem Pharma

2 people are tracked at Ra Chem Pharma (2 in leadership); the tracked headcount is 1,138.

NameRoleGroup
Ravi K Yerra
Co-Founder & Executive DirectorLeadership
J Rajender Rao
Co-FounderLeadership
Premium access

Complete people profiles for Ra Chem Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Ra Chem Pharma

Figures of Ra Chem Pharma Limited, the primary company behind Ra Chem Pharma, for FY 2021. Revenue was ₹621 Cr (+15% year on year). Net profit was ₹77.80 Cr (13% margin). EBITDA was ₹132 Cr (21% margin). Revenue has grown at a compounded annual rate of +12% over three years.

  • ₹621 CrRevenue · FY 2021 · +15% YoY
  • ₹77.80 CrNet profit · 13% margin
  • ₹132 CrEBITDA · 21% margin
  • ₹8.50 CrPaid-up capital
  • 1,138Employees (provident fund records)
  • +12%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Ra Chem Pharma Limited are on its company page.

Premium access

Detailed financial statements for Ra Chem Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Ra Chem Pharma

6 dated milestones of Ra Chem Pharma across 24 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ra Chem Pharma is founded.
  2. Funding First funding round of $920K.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Unspecified, of $340K.
  5. Exit Acquired by Micro Labs.
  6. Exit Acquired by Advent International.

Competitors of Ra Chem Pharma

Ra Chem Pharma has 3 listed competitors in our database, 1 of them funded. They include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
indoco.com1947Mumbai, India6,291
APIs manufacturing and formulation services are provided in therapeutic segments.
concordbiotech.com2000Ahmedabad, India1,598
APIs and enzymes are manufactured through fermentation by the CDMO.
bdrpharma.com2003Mumbai, India$88.16M1,864
APIs and finished products are developed and manufactured.
Premium access

Detailed competitors of Ra Chem Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Ra Chem Pharma

Websites that share an audience with Ra Chem Pharma (rachempharma.com).

Similar websites

Websites whose visitors overlap most with Ra Chem Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
indswiftlabs.com
100%
4.2K#3,680,932View details
vasudhapharma.com
92%
6.7K#1,818,910View details

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Ra Chem Pharma (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ra Chem Pharma

Premium access

Complete news archive for Ra Chem Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ra Chem Pharma

Ra Chem Pharma was founded in 1996 and raised its 1st funding round 10 years after it was founded.

Ra Chem Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Ra Chem Pharma has 1,138 employees.

The primary company behind Ra Chem Pharma, Ra Chem Pharma Limited, reported revenue of β‚Ή621 Cr for FY 2021, up 15% year on year.

RA Chem Pharma is a contract developer manufacturer of API formulations. They provide bioanalytical services such as HPLC GC, synthesize impurities working standards. Their API products are duloxetine, venlafaxine, orlistat, itraconazole, etc. The company is specialized in formulations development of oral control release site-specific release deliveries for anti-spasmodic, non-steroidal anti-inflammatory, anti-anxieties alpha1 receptor blockers. The company also claims to have completed more than three hundred BABE studies for various regulatory agencies.

Ra Chem Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Indoco Remedies.

Ra Chem Pharma has 6 investors. Key investors include Joflo Industries, Ontario, Orchem International Trading, Laxmi RA, and Advent International.

The valuation of Ra Chem Pharma is $17.09M as of Jun 2013.

Ra Chem Pharma operates through Ra Chem Pharma Limited.

Yes. Ra Chem Pharma was acquired by Advent International in July 2020.

The legal entities of Ra Chem Pharma currently have 8 directors, including Shweta Jalan, Abhijit Mangalmoy Mukherjee, Venkatanaga Kali Vetukuri Vara Prasada Raju and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available